Recent studies have demonstrated that aural cholesteatoma features intense DNA turnover in the germinati ve layer of the matrix and an immune response in the wall of the cyst, which trigger a chain reaction. 5-Fluorouracil, an antimetabolitic agent that is also effective topically, was applied to the cyst wall in initial cholesteatoma, in relapsing cholesteatoma (even transtympanically) and in large exudative cavities resulting from attico-antrectomy: in all cases, it inhibited the formation of keratin and reduced the mucous hypersecretion. These results have persisted even after 12 months of suspending treatment.
Get full access to this article
View all access options for this article.
References
1.
FerlitoA.A review of the definition, terminology and pathology of aural cholesteatoma. J.Laryngol Otol1993; 107: 483–8.
2.
LimD.J., SaundersW.H.Acquired cholesteatoma: light and electron microscopic observations.Ann Otol Rhinol Laryngol1972; 81: 2–12.
3.
FriedmannI.The pathology of epidermoid cholesteatoma: human and experimental, in: Cholesteatoma First Intern Conference: McCabeB.F., SadeJ., AbramsonM. (eds): BirminghamAesculapius1977; 10–22.
4.
PaludettiG., AlmadoriG., OttavianiF. et al. Contributo alio studio degli aspetti ultrastrutturali del colesteatoma dell’ orecchio medio. Acta Otorhinolaryngol.Ital.1989; 9: 169–80.
5.
SaggeseD., ModugnoG.C., CasolinoD.Quadri clinici essenziali e loro caratteristiche al momento presente. II Colesteatoma. In: Patologiae Chirurgia dell’ orecchio medio.PiroddaE. (ed): Editrice CompositoriBologna, 1992; 55–72.
6.
LimD.J., HusslB.Pathogenesis of cholesteatoma, Third intern. conference on cholesteatoma and mastoid surgery. Abstract.Copenhagen, 1988; 4: 9.
7.
CavicchiO., LimarziM., MaraniM.Istopatogenesi del colesteatoma. In: Patologia e Chirurgia dell'orecchio medio.PiroddaE. (ed): CompositoriEditrice, Bologna, 1992; 95–102.
8.
PassaliD., LaurielloM.I rapporti naso-tubarici: dalla fisiologia alla patologia. In: Nose & eustachian tube.PassaliD. (ed): CIC Ediz. Intern.Roma, 1989; 19–26
9.
OttavianiA., OttavianiF.Rapporti tra naso e tuba di eustachio. in: Nose & eustachian tube.PassaliD. (ed): CIC Ediz Item.Roma, 1989; 93–108.
10.
LinoY., ToriyamaM., OgawaH., KawakamiM.Cholesteatoma debris as an activator of human monocytes: Potentiation of production of tumor necrosis factor. Acta Otolaryngol.(Stockh)1990; 110: 410–415.
11.
BellussiL., DiGirolamoA., PassaliD.Study of B and T lymphocytes and Langerhans’ cells in relapsing and non relapsing cholesteatoma. Third Intern. Conference on cholesteatoma and mastoid surgery. Abstract. Copenhagen, 1988; 48: 32.
12.
VeldmanJ.E.The Langerhans’ T-cell repertoire in cholesteatoma. in: Cholesteatoma and mastoid surgery. Proceedings of third intern. Conference and cholesteatoma and mastoid surgery. TosM., ThomsenJ., PeitersenE., (eds): Kugler & Ghedini Publ.Amsterdam, 1989; 157–63.
13.
PassaliD., BellussiL.The importance of B and T lymphocytes and Langerhans’ cells in relapsing and non relapsing cholesteatomas.In: cholesteatoma and mastoid surgery. Proceedings of third intern. Conference on cholesteatoma and mastoid surgery. TosM., ThomsenJ., PeitersenE. (eds): Kugler & Ghedini Publ.Amsterdam, 1989; 165–70.
14.
MogiG., IchiliyaJ., KawauchiH.Immunology in cholesteatoma. in: cholesteatoma and mastoid surgery. Proceedings of the third intern. Conference on Cholesteatoma and Mastoid Surgery. TosM., ThomsenJ., PeitersenE., (eds): Kugler & Ghedini PublAmsterdam, 1989; 153–5.
15.
MayotD., BeneM.C., WayoffM.Immunological characteristics of human cholesteatoma matrix. in: Cholesteatoma and mastoid surgery. Proceedings of the third intern. Conference on cholesteatoma and mastoid surgery. TosM., ThomsenJ., PeitersenE., (eds): Kugler & Ghedini PublAmsterdam, 1989; 181–2.
16.
MartiniA., BoniG., ComacchioF.Middle ear mucosa histopathology and immunoistochemical changes in chronic suppurative and cholesteatomatous otitis media. Third intern. Conference on cholesteatoma and mastoid surgery.Abstract, Copenhagen, 1988; 52: 34.
17.
AhnJ.M., HuangC.C., AbramsonM.Localization of interleuchin-I in human cholesteatoma.Am J Otolaryngol Head Neck Surg1990; 112: 71–7.
18.
OttavianiF., SambataroC., MantovaniM.Middle ear cholesteatoma. A cytodiagnostic study of the cellular proliferative activity. In: Cholesteatoma and mastoid surgery. Proceedings of the third intern. Conference on cholesteatoma and mastoid surgery. TosM., Thomsen, PeitersenE., (eds): Kugler & Ghedini PublAmsterdam, 1989; 117–124.
19.
PiroddaE., CavicchiO.Immunohistochemical characteristics of keratins in cholesteatoma and epithelia of middle ear cavities. In: Cholesteatoma and mastoid surgery. Proceedings of the third intern. Conference on cholesteatoma and mastoid surgery. TosM., ThomsenJ., PeitersenE., (eds): Kugler & Ghedini PublAmsterdam, 1989; 107–10.
20.
OhyamaH., ShimaT.Cholesteatoma and arachidonic acid cascade metabolites. Third intern. Conference on cholesteatoma and mastoid surgery.Abstract, Copenhagen, 1988; 50: 33.
21.
JungT.T.K., JuhnS.K.Prostaglandins in human cholesteatoma and granulation tissue.Am J Otol1988; 9: 197–202.
22.
CholeR.A.Cellular and subcellular events of bone resporption in human and experimental cholesteatoma: the role of osteoclasts.Laryngoscope1984; 94: 76–95.
23.
JohnsonJ.T., MyersE.N., MayernikD.G.Adjuvant methotrexate-5-fluorouracil for extracapsular squamous cell carcinoma in cervical metastasis.Laryngoscope1990; 100: 590–2.
24.
EaglsteinW.H., WeinsteinG.D., FrostP.Fluorouracil: mechanism of action in human skin and actinic keratoses.Arch Dermatol1970; 101: 132–9.
25.
WarnockG.R., FullerR.P.Jr., PelleuG.B.Jr., Evaluation of 5-fluorouracil in the treatment of actinic keratosis of the lip.Oral Surg Med Oral Pathol1981; 52: 501–5.
26.
GoetteD.K.Topical chemotherapy with 5-fluorouracil.J Am Acad Dermat1981; 4: 633–49.
27.
SmithM.F.W.The topical use of 5-fluorouracil in the ear in the management of cholesteatoma and excessive mucous secretion.Laryngoscope1985; 95: 1202–3.
28.
PivottiG., CazzatoG.Uso topico del 5-fluorouracile nel trattamento dell’ otite media cronica colesteatomatosa e secretiva. I° Congr Soc Triveneta ORL, Abano T. (Padova), Abstract 1988.
29.
SalaT.La terapia medica nel colesteatoma dell'orecchio medio. Padova Abano T. Atti XXIII Congr Naz Soc It Audiologia 1993 (Oct); 13-16:115.
30.
WrightC.C., BirdL.L., MeyerhoffW.L.Effect of 5-fluorouracil in cholesteatoma development in an animal model.Am J Otolaryngol Head Neck Surg1991; 12: 133–8.
